Research Article

Gambaran proporsi dan faktor resiko anemia pada pasien diabetes melitus di RSUP Sanglah, Bali, Indonesia

Komang Satvika Yogiswara , Sianny Herawati, I Nyoman Wande

Komang Satvika Yogiswara
Mahasiswa Program Studi Sarjana Kedokteran dan Profesi Dokter, Fakultas Kedokteran, Universitas Udayana, Bali, Indonesia. Email: komangsatvikayogiswara@gmail.com

Sianny Herawati
Departemen Patologi Klinik, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia

I Nyoman Wande
Departemen Patologi Klinik, Fakultas Kedokteran, Universitas Udayana, RSUP Sanglah, Bali, Indonesia
Online First: April 22, 2021 | Cite this Article
Yogiswara, K., Herawati, S., Wande, I. 2021. Gambaran proporsi dan faktor resiko anemia pada pasien diabetes melitus di RSUP Sanglah, Bali, Indonesia. Intisari Sains Medis 12(1): 171-176. DOI:10.15562/ism.v12i1.882


Background: Patients with Type 2 Diabetes Mellitus (T2DM) are known to suffer from anemia as a direct or indirect result of their diabetes. In Indonesia, there are no studies that have looked at anemia in DM patients and the risk factors that influence it. Therefore, this study aims to determine the proportion and risk factors for anemia in T2DM patients at Sanglah General Hospital, Bali, Indonesia.

Methods: This study is a descriptive study with a cross-sectional approach that uses secondary data from medical records determined by the Purposive Sampling technique. The data obtained according to the inclusion and exclusion criteria were 100 data which were then processed with SPSS version 23 for Windows.

Results: In this study, it was found that 15.00% of T2DM patients in Sanglah General Hospital suffered from anemia. It was found that the risk factor that influenced the occurrence of anemia in T2DM patients was Chronic Kidney Disease (CKD) (r=0.581; p=0.000). Variable gender, HbA1c levels, BMI, type of drug, and the number of drugs were not associated with anemia in T2DM patients (p> 0.05).

Conclusion: The CKD condition was known significantly as a factor affecting the occurrence of anemia in T2DM patients at Sanglah General Hospital.

 

Latar belakang:  Pasien dengan Diabetes Melitus Tipe 2 (DMT2) diketahui dapat menderita anemia sebagai akibat langsung maupun tidak langsung dari diabetes yang mereka derita. Di Indonesia, belum ditemukan adanya penelitian yang melihat anemia pada pasien DM serta faktor resiko yang mempengaruhinya. Oleh karena itu penelitian ini bertujuan untuk mengetahui proporsi dan faktor risiko anemia pada pasien DMT2 di RSUP Sanglah, Bali, Indonesia.

Metode: Penelitian ini merupakan penelitian deskriptif dengan pendekatan potong lintang dimana menggunakan data sekunder rekam medis yang ditentukan dengan teknik Purposive Sampling. Data yang didapat sesuai kriteria inklusi dan eksklusi adalah 100 data yang kemudian diolah dengan SPSS versi 23 untuk Windows.

Hasil: Pada studi ini ditemukan bahwa 15,00% pasien DMT2 di RSUP Sanglah menderita anemia, ditemukan bahwa faktor resiko yang mempengaruhi terjadinya anemia pada pasien DMT2 adalah kondisi Penyakit Ginjal Kronis (PGK) (r=0,581; p=0,000). Variabel jenis kelamin, kadar HbA1c, IMT, jenis obat, dan jumlah obat tidak berhubungan dengan kondisi anemia pada pasien DMT2 (p>0,05).

Kesimpulan: Keadaan PGK diketahui secara bermakna sebagai faktor yang mempengaruhi terjadinya anemia pada pasien DMT2 di RSUP Sanglah.

References

Schuster DP, Duvuuri V. Diabetes mellitus. Clin Podiatr Med Surg. 2002;19(1):79-107.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9thedition. Diabetes Res Clin Pract. 2019;157:1-10.

Mihardja L, Soetrisno U, Soegondo S. Prevalence and clinical profile of diabetes mellitus in productive aged urban Indonesians. J Diabetes Investig. 2014;5(5):507-512.

Suastika K, Semadi IMS, Dwipayana IMP, Saraswati MR, Gotera W, Budhiarta AAG, et al. Dyslipidemia in diabetes: a population-based study in Bali. Int J Gen Med. 2019;12:313-321.

Chaparro CM, Suchdev PS. Anemia epidemiology, pathophysiology, and etiology in low- and middle-income countries. Ann N Y Acad Sci. 2019;1450(1):15-31.

Breymann C. Iron Deficiency Anemia in Pregnancy. Semin Hematol. 2015;52(4):339-347.

Andriastuti M, Ilmana G, Nawangwulan SA, Kosasih KA. Prevalence of anemia and iron profile among children and adolescent with low socio-economic status. Int J Pediatr Adolesc Med. 2020;7(2):88-92.

Kaur B, Henry J. Micronutrient status in type 2 diabetes: a review. Adv Food Nutr Res. 2014;71:55-100.

Yang W, Cai X, Wu H, Ji L. Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes. 2019;11(9):729-743.

Sharif A, Younus S, Baig K, Ali NH. Prevalence and Risk of Anaemia in Type-2 Diabetic Patients. Health. 2014;6(12):1415-1419.

Feteh VF, Choukem SP, Kengne AP, Nebongo DN, Ngowe-Ngowe M. Anemia in type 2 diabetic patients and correlation with kidney function in a tertiary care sub-Saharan African hospital: a cross-sectional study. BMC Nephrol. 2016;17:29.

AlDallal SM, Jena N. Prevalence of Anemia in Type 2 Diabetic Patients. J Hematol. 2018;7(2):57-61.

Fiseha T, Adamu A, Tesfaye M, Gebreweld A. Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia. PLoS One. 2019;14(9):e0222111.

Mulyani WRW, Sanjiwani MID, Sandra, Prabawa IPY, Lestari AAW, Wihandani DM, et al. Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2020;13:559-568.

Taderegew MM, Gebremariam T, Tareke AA, Woldeamanuel GG. Anemia and Its Associated Factors Among Type 2 Diabetes Mellitus Patients Attending Debre Berhan Referral Hospital, North-East Ethiopia: A Cross-Sectional Study. J Blood Med. 2020;11:47-58.

Adejumo BIG, Dimkpa U, Ewenighi C, Onifade AA, Mokogwu AT, Tosan A, et al. Incidence and risk of anemia in type-2 diabetic patients in the absence of renal impairment. Health; 2012;4(6):304-308.

Antwi-Bafour S, Hammond S, Adjei JK, Kyeremeh R, Martin-Odoom A, Ekem I. A case-control study of prevalence of anemia among patients with type 2 diabetes. J Med Case Rep. 2016;10(1):110.

Fiseha T, Adamu A, Tesfaye M, Gebreweld A. Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia. PLoS One. 2019;14(9):e0222111.

Barbieri J, Fontela PC, Winkelmann ER, Zimmermann CE, Sandri YP, Mallet EK, et al. Anemia in Patients with Type 2 Diabetes Mellitus. Anemia. 2015;2015:354737.

Thambiah SC, Samsudin N, George E, Ranjit LK, Saat NS, Hussein Z, et al. Anaemia in Type 2 Diabetes elitus (T2DM) Patients in Hospital PutraJaya. Malaysian Journal of Medicine and Health Science. 2015;11(1):49-61

Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metab. 2015;41(1):18-27.

Seufert J, Lübben G, Dietrich K, Bates PC. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clin Ther. 2004;26(6):805-818.

Louisa M, Takeuchi M, Takeuchi M, Nafrialdi, Setiabudy R. A meta-analysis on treatment effects of thiazolidinediones for type 2 diabetes mellitus in Asian populations. Acta Med Indones. 2011;43(1):39-52.

Hasslacher C, Collenberg E, Möcks J. Effect of insulin analogs on the decline of hemoglobin in diabetic patients with nephropathy. Exp Clin Endocrinol Diabetes. 2010;118(6):341-345.


No Supplementary Material available for this article.
Article Views      : 179
PDF Downloads : 73